Quantib is a radiology AI company that focuses on clinical solutions for prostate cancer, breast cancer and neurodegeneration. The company was founded as a spin-off of the Erasmus Medical Centre in Rotterdam.
Quantib has multiple AI-based solutions, including Quantib Prostate for analysis of prostate MR images and Quantib ND to quantify brain abnormalities on MRI. The company’s solutions are deployed through its AI Node platform for seamless workflow integration. It has customers in more than 20 countries worldwide, including the US.